Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | IL-4 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
(what is this?) (verify) |
Pascolizumab is a humanized monoclonal antibody for the treatment of asthma. [1] A Phase II clinical trial in patients with symptomatic glucocorticoid naive asthma was conducted in 2001/2002. [2] Development was discontinued as it showed little benefit. [3]